Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maxadilan induced dermal blood flow in healthy volunteers
NCT02355756Phase 1Completed
- Sponsor
- UZ Leuven
- Start
- Jan 2015
- Primary completion
- Apr 2015
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, open-label trial of maxadilan (2 arms), sponsored by UZ Leuven. Primary endpoints: Change in dermal blood flow induced by intradermal injections of maxadilan at Day 15, Changes in vital signs and 3 more. Started Jan 2015; status: completed.
02
Drugs
maxadilan
Beyond the preview
Go deeper on NCT02355756.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02355756.